Universal Health Servs Q2 2024 GAAP EPS $4.31 Beats $3.32 Estimate, Sales $3.907B Beat $3.864B Estimate
Portfolio Pulse from Benzinga Newsdesk
Universal Health Services (NYSE: UHS) reported strong Q2 2024 earnings, with GAAP EPS of $4.31 beating the $3.32 estimate and sales of $3.907 billion surpassing the $3.864 billion estimate. This represents a 10.12% increase in sales compared to the same period last year.
July 24, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Universal Health Services (NYSE: UHS) reported Q2 2024 GAAP EPS of $4.31, beating the $3.32 estimate by 29.82%. Sales of $3.907 billion also surpassed the $3.864 billion estimate, marking a 10.12% increase from the same period last year.
The significant beat on both EPS and sales estimates, along with a notable year-over-year sales increase, is likely to positively impact UHS's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100